Anyone experiencing persistent memory problems, trouble with language or reasoning, or significant changes in personality should talk to their doctor about getting an Alzheimer’s blood test. These tests—which measure biomarkers like phosphorylated tau and amyloid-beta in the bloodstream—can now detect Alzheimer’s disease pathology years before symptoms become severe, sometimes even before cognitive decline is noticeable. A 68-year-old woman who noticed she was forgetting the names of her bridge-club friends and misplacing her keys more often might be a candidate for testing, especially if her mother had dementia.
Blood tests for Alzheimer’s are not routine screenings for everyone. However, they are increasingly recommended for people who have cognitive concerns, a family history of dementia, or risk factors like untreated hypertension or high cholesterol. The tests are particularly useful for those already experiencing mild cognitive impairment or early symptoms of dementia, as they can help doctors understand whether Alzheimer’s pathology is driving the cognitive changes.
Table of Contents
- Who Is At Highest Risk for Alzheimer’s Disease?
- What Symptoms Suggest You Need Testing?
- Should People With a Family History Get Tested Early?
- When Should You Schedule Testing With Your Doctor?
- What Are the Limitations of Alzheimer’s Blood Tests?
- Cost, Insurance, and Access Considerations
- Different Blood Tests and What They Measure
Who Is At Highest Risk for Alzheimer’s Disease?
Age is the strongest risk factor for Alzheimer’s disease. The disease becomes more common after age 65, and risk roughly doubles every five years after that point. By age 85, about one in three people has Alzheimer’s or another dementia. If you’re in your 60s or 70s and noticing memory issues, or if you’re in your 80s with any cognitive changes, a blood test can help establish whether Alzheimer’s pathology is present.
Genetic factors also play a significant role. Having a first-degree relative—a parent or sibling—with Alzheimer’s increases your risk. People who carry the APOE4 gene, which can be identified through genetic testing, have a much higher lifetime risk of developing Alzheimer’s. However, carrying APOE4 does not guarantee you will develop dementia; some people with the gene never develop the disease. A 55-year-old man whose father and aunt both had early-onset Alzheimer’s might consider testing even if he has no current symptoms, as early identification of biomarkers could open doors to preventive interventions.
What Symptoms Suggest You Need Testing?
Persistent memory loss that interferes with daily life is the most obvious reason to seek testing. Forgetting where you parked your car occasionally is normal aging. Repeatedly forgetting appointments despite writing them down, or telling the same story multiple times in a single conversation, warrants evaluation. Memory changes accompanied by difficulty finding the right words, struggling with complex tasks like managing finances, or becoming disoriented in familiar places are red flags that should prompt a conversation with your doctor about blood testing. Behavioral and personality changes can also indicate the need for testing.
Some people with early Alzheimer’s disease become withdrawn, anxious, or irritable. Others show poor judgment—like excessive spending or neglecting personal hygiene—that represents a change from their baseline personality. It’s important to note that not all cognitive decline is Alzheimer’s; depression, thyroid problems, vitamin B12 deficiency, sleep apnea, and medication side effects can all mimic early dementia symptoms. This is a critical limitation of blood tests: they can only identify whether Alzheimer’s pathology is present, not whether it is the cause of a person’s symptoms. Your doctor will use cognitive testing, imaging, and other evaluations alongside blood biomarkers to build a complete picture.
Should People With a Family History Get Tested Early?
A family history of Alzheimer’s disease is a legitimate reason to discuss testing with your doctor, even if you have no symptoms. The Dominantly Inherited Alzheimer Network (DIAN) has identified families with rare genetic mutations that cause early-onset Alzheimer’s, sometimes in people in their 40s or 50s. If your family history suggests early-onset disease—a parent developing symptoms before age 65—genetic counseling and early biomarker testing may be appropriate.
For the much larger group of people with a family history of typical late-onset Alzheimer’s, the decision is more nuanced. Some researchers and doctors argue that cognitively normal people at risk should have baseline blood biomarker testing to establish whether they have subclinical Alzheimer’s pathology. Others caution against widespread testing of asymptomatic people because the results can be difficult to interpret and may cause unnecessary anxiety. A 72-year-old daughter whose mother developed Alzheimer’s at 80 might learn that she already has amyloid and tau in her blood—information that is medically interesting but doesn’t change current clinical recommendations unless she also shows early cognitive decline.
When Should You Schedule Testing With Your Doctor?
The first step is scheduling an appointment with your primary care doctor or a neurologist to discuss cognitive concerns. Bring a list of specific memory or thinking problems you’ve noticed, note when they started, and mention anyone in your family with dementia. Your doctor will perform cognitive screening tests—often the Montreal Cognitive Assessment (MoCA) or Mini-Cog—which take 10 to 15 minutes and can detect mild impairment that you or your family might not have articulated clearly. If your doctor suspects mild cognitive impairment or early dementia based on your history and cognitive screening, they may recommend blood biomarker testing.
The advantage of blood tests over older diagnostic methods—like PET imaging or cerebrospinal fluid sampling—is that they are minimally invasive, widely available, and relatively affordable. A simple blood draw at your doctor’s office or lab is all that’s required. However, availability varies by location and insurance coverage, and not all primary care clinicians are familiar with ordering or interpreting these tests. You may be referred to a neurologist or cognitive specialist for comprehensive evaluation.
What Are the Limitations of Alzheimer’s Blood Tests?
Blood biomarker tests can detect Alzheimer’s pathology in the brain, but they cannot predict with certainty whether you will develop dementia or when symptoms might appear. Some people with significant amyloid and tau in their blood remain cognitively normal throughout their lives. The tests also cannot distinguish between different types of dementia; other conditions like Lewy body dementia, vascular dementia, or frontotemporal dementia require additional evaluation and sometimes imaging or specialist assessment. Another important limitation is that test results are not diagnostic on their own. A positive biomarker test means Alzheimer’s pathology is present, but your doctor still needs cognitive testing, medical history, and sometimes brain imaging to confirm diagnosis.
There is also the psychological impact of a positive test result. Learning that you have Alzheimer’s pathology in your brain can trigger anxiety, especially if you have no symptoms. Some people find this knowledge motivating—it encourages them to adopt lifestyle changes and stay engaged with medical follow-up. Others experience significant distress about a disease they may never develop or that may progress very slowly. Before ordering a test, discuss with your doctor how you would feel receiving results and what your plan would be if the test is positive.
Cost, Insurance, and Access Considerations
The cost of Alzheimer’s blood biomarker tests ranges from a few hundred to over a thousand dollars, depending on the specific tests ordered and your location. Many insurance plans now cover these tests, particularly if there is documented cognitive impairment or a strong family history. Medicare generally covers biomarker testing when ordered by a neurologist or when there is clear medical indication.
However, coverage varies, and you should confirm with your insurance before the test or ask your doctor’s office to verify coverage. Access to testing depends on whether a specialized lab or clinic is available in your area. Major academic medical centers and neurology practices typically offer these tests, but rural areas and smaller towns may have limited options. Telehealth consultations with neurologists have made it easier for some people to get expert evaluation and test ordering without traveling long distances, though the blood draw itself still requires an in-person visit to a local lab or clinic.
Different Blood Tests and What They Measure
Several blood tests for Alzheimer’s are now available, and your doctor may order one or more depending on your situation. The phosphorylated tau variants (p-tau181, p-tau217, p-tau384) are considered sensitive markers of Alzheimer’s pathology in the brain. Amyloid-beta 42 and amyloid-beta 40 are also measured and help establish the amyloid profile.
Neurofilament light chain (NfL) is a marker of neurodegeneration that can indicate how much damage is occurring in brain cells. Different labs and companies offer different combinations of these biomarkers, so the specific tests you receive may depend on which lab your doctor uses and what your insurance covers. Understanding which biomarkers are being measured and what they indicate will help you have a more informed conversation with your doctor about what your results mean for your brain health going forward.
